bortezomib
Drug Details
- Generic Name
- bortezomib
- Brand Names
- BORTEZOMIB, Bortezomib, bortezomib, VELCADE
- Application Number
- ANDA205533
- Sponsor
- Cilag AG
- NDC Codes
- 10
- Dosage Forms
- POWDER, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- BORTEZOMIB
Indications and Usage
1 INDICATIONS AND USAGE Bortezomib for Injection is a proteasome inhibitor indicated for: treatment of adult patients with multiple myeloma ( 1.1 ) treatment of adult patients with mantle cell lymphoma ( 1.2 ) 1.1 Multiple Myeloma Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma. 1.2 Mantle Cell Lymphoma Bortezomib for Injection is indicated for the treatment of adult patients with mantle cell lymphoma.